WAYNE, Pa.–(BUSINESS WIRE)–Inverness Graham, a Philadelphia-based buyout firm focused on acquiring innovative companies where technology is transforming traditional industry, announced today that its single-use surgical products manufacturer, Innovia…
Woman referred for asymmetric diffuse retinal hemorrhages
A 69-year-old woman was referred to the retina service for abnormal posterior segment findings.The patient’s medical history was notable for bilateral hearing loss and type 2 diabetes diagnosed 10 years ago. While her HbA1c peaked to 12.7% 2 years prio…
Regenerative approaches to endothelial disease: What’s on the horizon?
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.While endothelial keratoplasty (EK) has taken off and…
Canabrava Ring offers advantages for iris expansion
Our guest columnist is Sérgio Felix Canabrava, MD, of Brazil, who pioneered the Canabrava IOL fixation technique. In this column, he explains the Canabrava Ring iris expander.Priya Narang, MS, and Amar Agarwal, MS, FRCS, FRCOphth OSN Complications Cons…
Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)
GENEVA–(BUSINESS WIRE)–Alcon to Acquire LumiThera and its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)
VIDEO: Tyrosine kinase inhibitors may help alleviate wet AMD treatment burden
LAS VEGAS — In this video, Victor H. Gonzalez, MD, discusses “exciting” presentations at Clinical Trials at the Summit on wet age-related macular degeneration treatments, specifically those on tyrosine kinase inhibitors.“Hopefully, in the not too dista…